openFDA 药品召回·· 21 天前精选AI 评分43
Hikma旗下Abirtega(醋酸阿比特龙)250mg片剂因重量均一性不合格被召回
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
AI 导读
openFDA药品召回记录显示,Abirtega(醋酸阿比特龙)USP 250 mg、120片装处方药因片剂重量均一性不符合标准被召回。该产品由Arab Pharmaceuticals Manufacturing PSC为Hikma Pharmaceuticals USA Inc.生产,NDC为82249-011-12。
推荐理由
openFDA召回记录显示阿比特龙仿制药因片重均一性不合格被召回,可了解该批次的具体规格与生产信息。
来源:openFDA 药品召回 · api.fda.gov